Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Which treatment for hyperprolactinemic females?

G Strauch

    Hormone Research
    |January 1, 1985
    PubMed
    Summary

    This review examines chronic hyperprolactinemia risks and treatments. While breast cancer risk is low, pituitary adenoma growth is uncommon, and cures are rare with current therapies.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Assessment of the Flow Dynamic of a Mining Lake by Stable Isotope Investigations.

    Isotopes in environmental and health studies·2017
    Same author

    Physical activity and type 2 diabetes. Recommandations of the SFD (Francophone Diabetes Society) diabetes and physical activity working group.

    Diabetes & metabolism·2013
    Same author

    Mineral- und heilwässer in sachsen - eine isotopenanalytische charakterisierung.

    Isotopes in environmental and health studies·2011
    Same author

    Evaluation of xenobiotic impact on urban receiving waters by means of statistical methods.

    Water science and technology : a journal of the International Association on Water Pollution Research·2010
    Same author

    Mass fluxes and spatial trends of xenobiotics in the waters of the city of Halle, Germany.

    Environmental pollution (Barking, Essex : 1987)·2007
    Same author

    Inflammatory activity in river-water samples.

    Environmental toxicology·2004

    Area of Science:

    • Endocrinology
    • Oncology
    • Neurosurgery

    Background:

    • Chronic hyperprolactinemia presents risks and necessitates treatment evaluation.
    • Understanding the long-term implications and therapeutic outcomes is crucial.

    Purpose of the Study:

    • To review current evidence on risks associated with chronic hyperprolactinemia.
    • To assess the benefits and hazards of available treatment modalities.
    • To guide treatment choices based on clinical scenarios.

    Main Methods:

    • Literature review of existing evidence on hyperprolactinemia.
    • Analysis of risks including breast cancer incidence and pituitary adenoma growth.
    • Evaluation of treatment efficacy for dopaminergic drugs, surgery, and radiotherapy.

    Main Results:

    • Long-term risks like breast cancer are unlikely; pituitary adenoma growth occurs in a minority.
    • Dopaminergic drugs rarely achieve a cure; pituitary surgery offers <50% cure rates.
    • Radiotherapy efficacy remains uncertain, with treatment choice depending on clinical context.

    Conclusions:

    • Chronic hyperprolactinemia management requires careful consideration of risks and limited cure rates.
    • Current treatments primarily focus on prolactin secretion control rather than disease eradication.
    • Personalized treatment strategies are essential for managing hyperprolactinemia effectively.

    Related Experiment Videos